AG0007YM

102625-64-9 | 1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-

Chemical structure of 1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-, CAS 102625-64-9
AG0007YM
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 102625-64-9
Catalog Number AG0007YM(AGN-PC-0ORQ37)
Chemical Name 1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-
IUPAC Name 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfanyl]-1H-benzimidazole
InChI InChI=1S/C16H15F2N3O3S/c1-22-13-5-6-19-12(14(13)23-2)8-25-16-20-10-4-3-9(24-15(17)18)7-11(10)21-16/h3-7,15H,8H2,1-2H3,(H,20,21)
InChI Key UKILEIRWOYBGEJ-UHFFFAOYSA-N
MDL Number MFCD07368273
Molecular Formula C16H15F2N3O3S
Molecular Weight 367.3704
SMILES COC1=C(OC)C(CSC2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
UNII BWZ6X03HIB
Synonyms
102625-64-9, Pantoprazole sulfide, 5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl)methyl]thio-1H-benzimidazole, 5-(Difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole, 5-Difluoromethoxy-2-{[(3,4-dimethoxy-2-pyridinyl)methyl]thio}-1H-benzimidazole, UNII-BWZ6X03HIB, BWZ6X03HIB, AK-56406, 1H-Benzimidazole, 6-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)thio)-, Pantoprazole thioether, Pantoprazole related compound B, 1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl]methyl]thio]-1H-benzimidazole, 5-(Difluoromethoxy)-2-[[(3,4-dimethoxypyridin-2-yl)methyl]sulphanyl]-1H-benzimidazole, 5-(Difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulphanyl}-1H-benzimidazole, 5-difluoromethoxy-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole, Pantoprazole related compound B [USP], PubChem20403, ACMC-1BOUK, Pantoprazole related compound B RS [USP], EC 700-025-3, KSC498E9N, SCHEMBL537800, H-258/28, Jsp000294, C16H15F2N3O3S, SCHEMBL13846375, CTK3J8296, DTXSID30145418, Pantoprazole sodium sesquihydrate specified impurity B [EP], UKILEIRWOYBGEJ-UHFFFAOYSA-N, BCP12247, EBD35810, KS-00000NN7, ZX-AP011973, ANW-14723, CD-756, MFCD07368273, PC3237, SBB070987, ZINC16158998, 5-Difluoromethoxy-2-(((3,4-dimethoxy-2-pyridyl)methyl)thio)-1H-benzimidazole, AKOS015895368, AKOS015965059, AC-8095, AN-8326, COR0003216, RP17804, TRA0031392, 5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)thio)-1H-benzimidazole, 5-(Difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfanyl)-1H-benzimidazole, AJ-68615, AS-11877, CC-21692, CJ-15445, SC-45552, AB0004563, AX8008748, RT-004452, TL8006118, FT-0642493, P2066, ST24044237, M-1107, 625D649, A800592, C-21060, I06-0607, J-000743, J-516335, 5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl)me, 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridyl)methyl]thio]benzimidazole, {2-[(3,4-dimethoxy(2-pyridyl))methylthio]benzimidazol-5-yloxy}difluoromethane, 5-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylthio)-1H-benzo[d]imidazole, 5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfanyl]-1H-benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl) methyl]thio]-1H-benzimidazole, 5-(Difluoromethoxy)-2-[[(3,4-Dimethoxy-2-Pyridinyl)Methyl]Sulfanyl]-1H-Benzimidazole, 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfanyl}-1H-1,3-benzodiazole, 5-(Difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]thio}-1H-benzimidazole, 5-(Difluoromethoxy)-2[[(3,4-dimethoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole, 5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl) methyl]thio-1H-benzimidazole, 5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl)methyl]thio-1Hbenzimidazole, 5-difluoromethoxy-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1h-benzimidazol, 6-(Difluoromethoxy)-2-(3,4-dimethoxy-2-pyridylmethylthio)-1H-benzoimidazole, 6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridinyl)methylthio]-1H-benzimidazole, 6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfanyl]-1H-benzimidazole, 6-[bis(fluoranyl)methoxy]-2-[(3,4-dimethoxypyridin-2-yl)methylsulfanyl]-1H-benzimidazole, Pantoprazole Related Compound B, United States Pharmacopeia (USP) Reference Standard, 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2-[(triphenylmethyl)-1H-tetrazol-5-yl][1,1-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid ethyl ester, CAPSO sodium salt, Pantoprazole Sulphide, Pantoprazole Sulfide 1g, 5-DIFLUOROMETHOXY-2-, CID9799341, CS-O-05990, 5-difluoromethoxy-2-{((3,4-dimethoxy-2-pyridinyl)methyl)thio}-1h-benzimidazole, 6-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylthio)-1H-benzo[d]imidazole, 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfanyl]-1H-benzoimidazole, 5-difluoromethoxy-2-[[(3,4-dimethoxy-2-pyridyl)methyl]thio]-1H-benzimidazole, 5-difluoromethoxy-2-[[(3,4-dimethoxy-2-pyridyl)methyl]thio]-1H-benzimidazole,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited